As the key channel of hepatic blood circulation, the portal vein plays a key role in the planning and implementation of minimally invasive liver surgery based on its branch morphology, location, and hemodynamic information. Intelligent imaging technology not only provides more reliable anatomical basis for precision liver resection, but also opens up new possibilities for per-sonalized planning and precise implementation of minimally invasive liver resection. The authors will review the application of portal vein imaging in minimally invasive surgery.

As the key channel of hepatic blood circulation, the portal vein plays a key role in the planning and implementation of minimally invasive liver surgery based on its branch morphology, location, and hemodynamic information. Intelligent imaging technology not only provides more reliable anatomical basis for precision liver resection, but also opens up new possibilities for per-sonalized planning and precise implementation of minimally invasive liver resection. The authors will review the application of portal vein imaging in minimally invasive surgery.

Oral squamous cell carcinoma (OSCC) has a high incidence of metastasis. Tumour immunotherapy targeting PD-L1 or PD-1 has been revolutionary; however, only a few patients with OSCC respond to this treatment. Therefore, it is essential to gain insights into the molecular mechanisms underlying the growth and metastasis of OSCC. In this study, we analysed the expression levels of protein kinase D3 (PKD3) and PD-L1 and their correlation with the expression of mesenchymal and epithelial markers. We found that the expression of PKD3 and PD-L1 in OSCC cells and tissues was significantly increased, which correlated positively with that of mesenchymal markers but negatively with that of epithelial markers. Silencing PKD3 significantly inhibited the growth, metastasis and invasion of OSCC cells, while its overexpression promoted these processes. Our further analyses revealed that there was positive feedback regulation between PKD3 and PD-L1, which could drive EMT of OSCC cells via the ERK/STAT1/3 pathway, thereby promoting tumour growth and metastasis. Furthermore, silencing PKD3 significantly inhibited the expression of PD-L1, and lymph node metastasis of OSCC was investigated with a mouse footpad xenograft model. Thus, our findings provide a theoretical basis for targeting PKD3 as an alternative method to block EMT for regulating PD-L1 expression and inhibiting OSCC growth and metastasis.
Animals ; B7-H1 Antigen/metabolism* ; Carcinoma, Squamous Cell ; Cell Line, Tumor ; Feedback ; Head and Neck Neoplasms ; Humans ; Mice ; Mouth Neoplasms ; Protein Kinase C ; STAT1 Transcription Factor ; Squamous Cell Carcinoma of Head and Neck